Alex Boches

Co-Founder

2025

Co-Founder

2022 - 2025

Teal is developing an advanced AI platform for multiomic analytics to enable researchers with a deeper understanding of aging and age-related disease.

Partner

2021 - 2025

FORM funds and incubates breakthrough science and technology to drive a new era in healthcare.

COO & US General Manager

2019 - 2021

Built and led our US business, establishing Baze as an early leader in personalized nutrition. Our mission was to develop a scientifically backed blood-based platform to enable the delivery of validated personalized health and nutrition interventions based on a person's unique deficiencies and needs. We were acquired by Nature's Way in December 2020.

Director

2015 - 2019

Pioneering AI company developing a natural language processing platform to help the world's largest corporations derive insights from large text datasets. Joined as a founding member of Quid's Healthcare and Life Sciences team where we built a $20M+ ARR business working with leading healthcare and pharma companies.

Business Development Lead

2014 - 2014

B2B healthcare platform developing one of the first end-to-end communications platform for healthcare. I joined as their first business hire to build out their payer growth strategy and business development function.

Business Analyst

2012 - 2014

Worked on numerous projects with clients across chemical and materials manufacturing, healthcare, and life sciences. Was an early member of Deloitte's advanced materials practice. On my last project, I supported a leading pharma VC in their effort to understand the emerging digital health landscape. This project introduced me to the start-up world and sparked a passion for AI and tech.

Honors Thesis Work

2008 - 2011

Conducted independent research projects related to the anti-cancer drug Laromustine. Researched the apoptotic pathways induced in cells when exposed to the drug.